[1] 张文喜, 段达荣, 张震宇, 等.参附注射液联合低分子肝素对小儿脓毒血症血浆NT-ProBNP、Cys、凝血功能和预后的影响[J].中国现代医学杂志, 2017, 27(2):61. doi: 10.3969/j.issn.1005-8982.2017.02.011
[2] 卢中秋, 卢才教, 洪广亮, 等.34例创伤弧菌脓毒症患者的流行病学特点及临床诊治[J].中华急诊医学杂志, 2009, 18(7):732. doi: 10.3760/cma.j.issn.1671-0282.2009.07.017
[3] 常瑜, 郝正玮, 郭霞, 等.参附注射液治疗脓毒血症的效果及影响因素的Logistic回归分析[J].实用药物与临床, 2015, 18(9):1055.
[4] DELLINGER RP, LEVY MM, RHODES A, et al.Surviving Sepsis Campaign:international guidelines for management of severe sepsis and septic shock, 2012[J].Intensive Care Med, 2013, 39(2):165. doi: 10.1007/s00134-012-2769-8
[5] 陈佳顺, 姚盛.参附注射液治疗难治性脓毒血症并休克的临床观察[J].中国实用医药, 2016, 11(19):161.
[6] 张国刚.参附注射液治疗30例脓毒症患者的临床观察[J].中国中医急症, 2015, 24(7):1268. doi: 10.3969/j.issn.1004-745X.2015.07.056
[7] 陈勉, 胡志华, 陈伟, 等.持续血液净化疗法治疗外伤继发性脓毒症临床效果及对高迁移率族蛋白1、肿瘤坏死因子-α和促血管生成素2的影响[J].中国现代医学杂志, 2014, 24(34):61. doi: 10.3969/j.issn.1005-8982.2014.34.015
[8] 田虹, 王洪霞.老年脓毒症患者凝血功能紊乱及与预后的关系[J].中国急救医学, 2014, 34(11):966. doi: 10.3969/j.issn.1002-1949.2014.11.03
[9] MAKI DG, ROSENTHAL VD, SALOMAO R, et al.Impact of switching from an open a closed infusion system on rates of central line-associated bloodstream infection:a meta-analysis of time-sequence cohort studies in 4 countries[J].Infect Control Hosp Epidemiol, 2011, 32(1):50. doi: 10.1086/657632
[10] LAI TS, WANG CY, PAN SC, et al.Risk of developing severe sepsis after acute kidney injury:a population-based cohort study[J].Crit Care, 2013, 17(5):R231. doi: 10.1186/cc13054
[11] 中华医学会重症医学分会.中国严重脓毒症/脓毒性休克治疗指南(2014)[J].中华内科杂志, 2015, 54(6):557.
[12] SAFAEI ASL A, DADASHZADEH P.Acute kidney injury in patients with paraquat intoxication; a case report and review of the literature[J].J Renal Inj Prev, 2016, 5(4):203. doi: 10.15171/jrip.2016.43
[13] 罗苑苑, 林新峰, 岳金芳, 等.从p38MAPK途径探讨参附注射液对脓毒症大鼠心功能的影响[J].广州中医药大学学报, 2017, 34(3):394.
[14] HEMANDEZ G, BRUHN A, CASTRO R, et al.The holistic view on perfusion monitoring in septic shock[J].Curt Opin Crit Care, 2012, 18(3):280. doi: 10.1097/MCC.0b013e3283532c08